Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant that has recently gained attention for its potential effects on mood and mental wellness. In this 2024 double-blind, placebo-controlled clinical trial, researchers studied the short-term effects of CBG on anxiety, stress, and mood in healthy adults. Participants received either CBG or a placebo and […]
Tag: CBG
CBG and CBD May Interact Differently Within the Body’s Detoxification Pathways (Pub. May 2026)
As research into hemp-derived cannabinoids continues to expand, scientists are learning that cannabinoids like CBD and CBG may affect the body in very different ways. In the study “Cannabigerol and cannabidiol differ in their ability to affect the AhR/CYP1A pathway in vitro,” researchers explored how these two cannabinoids interact with biological pathways connected to detoxification […]
CBG Demonstrates Anti-Inflammatory, Neuroprotective, and Antibacterial Activity (pub. Nov 2022)
Cannabigerol (CBG) is often called the “mother cannabinoid” because it serves as a precursor from which other major cannabinoids, including CBD and THC, are formed during the cannabis plant’s growth. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting growing interest in the compound for its potential […]